These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30284381)

  • 1. Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
    García-Fiñana M; Hughes DM; Cheyne CP; Broadbent DM; Wang A; Komárek A; Stratton IM; Mobayen-Rahni M; Alshukri A; Vora JP; Harding SP
    Diabetes Obes Metab; 2019 Mar; 21(3):560-568. PubMed ID: 30284381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
    Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
    Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
    Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
    J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.
    Olvera-Barrios A; Owen CG; Anderson J; Warwick AN; Chambers R; Bolter L; Wu Y; Welikala R; Fajtl J; Barman SA; Remagnino P; Chew EY; Ferris FL; Hingorani AD; Sofat R; Lee AY; Egan C; Tufail A; Rudnicka AR;
    BMJ Open Diabetes Res Care; 2023 Nov; 11(6):. PubMed ID: 37949472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.
    Rajalakshmi R; Shanthi Rani CS; Venkatesan U; Unnikrishnan R; Anjana RM; Jeba Rani S; UmaSankari G; Sivaprasad S; Raman R; Mohan V
    BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32475840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.
    Rajalakshmi R; Behera UC; Bhattacharjee H; Das T; Gilbert C; Murthy GVS; Pant HB; Shukla R;
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S21-S26. PubMed ID: 31937724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple risk stratification for time to development of sight-threatening diabetic retinopathy.
    Stratton IM; Aldington SJ; Taylor DJ; Adler AI; Scanlon PH
    Diabetes Care; 2013 Mar; 36(3):580-5. PubMed ID: 23150285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies?
    Owens DR; Gibbins RL; Lewis PA; Wall S; Allen JC; Morton R
    Diabet Med; 1998 Feb; 15(2):170-5. PubMed ID: 9507921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study.
    Forster AS; Forbes A; Dodhia H; Connor C; Du Chemin A; Sivaprasad S; Mann S; Gulliford MC
    Diabetes Care; 2013 Sep; 36(9):2663-9. PubMed ID: 23620476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect.
    Olvera-Barrios A; Rudnicka AR; Anderson J; Bolter L; Chambers R; Warwick AN; Welikala R; Fajtl J; Barman S; Remgnino P; Wu Y; Lee AY; Chew EY; Ferris FL; Hingorani A; Sofat R; A Egan C; Tufail A; Owen CG;
    Br J Ophthalmol; 2023 Nov; 107(12):1839-1845. PubMed ID: 37875374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of direct ophthalmoscopy for detection of diabetic retinopathy using fundus photographs as a reference standard.
    Ahsan S; Basit A; Ahmed KR; Ali L; Shaheen F; Ulhaque MS; Fawwad A
    Diabetes Metab Syndr; 2014; 8(2):96-101. PubMed ID: 24907174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme.
    Misra A; Bachmann MO; Greenwood RH; Jenkins C; Shaw A; Barakat O; Flatman M; Jones CD
    Diabet Med; 2009 Oct; 26(10):1040-7. PubMed ID: 19900237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
    Soto-Pedre E; Pinies JA; Hernaez-Ortega MC
    J Diabetes Complications; 2015; 29(4):508-11. PubMed ID: 25725582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.
    Zhang G; Chen H; Chen W; Zhang M
    Br J Ophthalmol; 2017 Dec; 101(12):1591-1595. PubMed ID: 28855195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.
    Scanlon PH; Aldington SJ; Leal J; Luengo-Fernandez R; Oke J; Sivaprasad S; Gazis A; Stratton IM
    Health Technol Assess; 2015 Sep; 19(74):1-116. PubMed ID: 26384314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of sight-threatening diabetic retinopathy and its awareness among patients with diabetes mellitus attending a tertiary care center in Kashmir, India.
    Kaushik M; Nawaz S; Qureshi TS
    Indian J Ophthalmol; 2021 Nov; 69(11):3123-3130. PubMed ID: 34708753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cystatin C in the detection of sight-threatening diabetic retinopathy in Asian Indians with type 2 diabetes.
    PramodKumar TA; Sivaprasad S; Venkatesan U; Mohan V; Anjana RM; Unnikrishnan R; Cherian J; Giridhar A; Gopalakrishnan M; Rajalakshmi R
    J Diabetes Complications; 2023 Aug; 37(8):108545. PubMed ID: 37348180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social determinants of diabetic retinopathy and impact of sight-threatening diabetic retinopathy: A study from Pune, India.
    Kulkarni S; Patil V; Kashikar R; Deshpande R; Dole K
    Indian J Ophthalmol; 2023 Feb; 71(2):358-362. PubMed ID: 36727320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.